2021 ESGO/ISUOG/IOTA/ESGE共识声明:卵巢肿瘤的术前诊断

2021-06-10 欧洲妇科肿瘤学会 Facts Views Vis Obgyn.2021 Jun 10;13(2).

2021年6月,欧洲妇科肿瘤学会(ESGO)联合国际妇产科超声学会(ISUOG)等多家学会组织共识发布了卵巢肿瘤的术前诊断共识。主要内容涉及影像检查技术,生物标志物和预测模型。

中文标题:

2021 ESGO/ISUOG/IOTA/ESGE共识声明:卵巢肿瘤的术前诊断

英文标题:

ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours

发布机构:

欧洲妇科肿瘤学会

发布日期:

2021-06-10

简要介绍:

2021年6月,欧洲妇科肿瘤学会(ESGO)联合国际妇产科超声学会(ISUOG)等多家学会组织共识发布了卵巢肿瘤的术前诊断共识。主要内容涉及影像检查技术,生物标志物和预测模型。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ESGO_ISUOG_IOTA_ESGE共识声明:卵巢肿瘤的术前诊断.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a9c961c002118327, title=2021 ESGO/ISUOG/IOTA/ESGE共识声明:卵巢肿瘤的术前诊断, enTitle=ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours, guiderFrom=Facts Views Vis Obgyn.2021 Jun 10;13(2)., authorId=0, author=, summary=2021年6月,欧洲妇科肿瘤学会(ESGO)联合国际妇产科超声学会(ISUOG)等多家学会组织共识发布了卵巢肿瘤的术前诊断共识。主要内容涉及影像检查技术,生物标志物和预测模型。, cover=https://img.medsci.cn/2021629/1624977712042_2020535.jpg, journalId=0, articlesId=null, associationId=1422, associationName=欧洲妇科肿瘤学会, associationIntro=, copyright=0, guiderPublishedTime=Thu Jun 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年6月,欧洲妇科肿瘤学会(ESGO)联合国际妇产科超声学会(ISUOG)等多家学会组织共识发布了卵巢肿瘤的术前诊断共识。主要内容涉及影像检查技术,生物标志物和预测模型。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=17475, tagName=卵巢肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=17475, guiderKeyword=卵巢肿瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4025, appHits=130, showAppHits=0, pcHits=406, showPcHits=3895, likes=0, shares=13, comments=4, approvalStatus=1, publishedTime=Tue Jun 29 23:46:32 CST 2021, publishedTimeString=2021-06-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Jun 29 22:42:25 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 17:10:20 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ESGO_ISUOG_IOTA_ESGE共识声明:卵巢肿瘤的术前诊断.pdf)])
2021 ESGO_ISUOG_IOTA_ESGE共识声明:卵巢肿瘤的术前诊断.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1069918, encodeId=144e10699186f, content=感谢,学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:18:37 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053240, encodeId=8c61105324042, content=学习的导向, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Mon Sep 20 11:31:10 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008720, encodeId=9c6c1008e20b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff25575336, createdName=ms1000001256854968, createdTime=Tue Aug 17 14:37:04 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996009, encodeId=a3129960090e, content=全英文可不懂!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Sun Jul 04 10:05:27 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-11-13 wrlssy

    感谢,学习了!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1069918, encodeId=144e10699186f, content=感谢,学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:18:37 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053240, encodeId=8c61105324042, content=学习的导向, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Mon Sep 20 11:31:10 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008720, encodeId=9c6c1008e20b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff25575336, createdName=ms1000001256854968, createdTime=Tue Aug 17 14:37:04 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996009, encodeId=a3129960090e, content=全英文可不懂!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Sun Jul 04 10:05:27 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-09-20 ms3000001592172450

    学习的导向

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1069918, encodeId=144e10699186f, content=感谢,学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:18:37 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053240, encodeId=8c61105324042, content=学习的导向, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Mon Sep 20 11:31:10 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008720, encodeId=9c6c1008e20b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff25575336, createdName=ms1000001256854968, createdTime=Tue Aug 17 14:37:04 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996009, encodeId=a3129960090e, content=全英文可不懂!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Sun Jul 04 10:05:27 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-08-17 ms1000001256854968

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1069918, encodeId=144e10699186f, content=感谢,学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:18:37 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053240, encodeId=8c61105324042, content=学习的导向, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Mon Sep 20 11:31:10 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008720, encodeId=9c6c1008e20b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff25575336, createdName=ms1000001256854968, createdTime=Tue Aug 17 14:37:04 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996009, encodeId=a3129960090e, content=全英文可不懂!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Sun Jul 04 10:05:27 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-07-04 湘雅科教

    全英文可不懂!

    0

拓展阅读

妊娠期卵巢肿瘤诊治专家共识(2020)

中国优生科学协会(CHBSA,China Healthy Birth Science Association) · 2020-05-15

2020 CNGOF指南:交界性卵巢肿瘤-第1部分:流行病学,生物病理学,影像学和生物标志物

法国国家妇产科医生协会(CNGOF,coll&egrave;ge national des gyn&eacute;cologues et obst&eacute;triciens francais) · 2020-11-04

2020 CNGOF指南:交界性卵巢肿瘤-第2部分:手术治疗,随访,激素替代治疗,生育管理以及保留生育力

法国国家妇产科医生协会(CNGOF,coll&egrave;ge national des gyn&eacute;cologues et obst&eacute;triciens francais) · 2020-11-04

卵巢肿瘤ADNEX MR评分系统的应用解读及研究进展

南通大学附属南通市妇幼保健院影像科 · 2023-06-20

卵巢肿瘤良恶性风险评估方法学中国专家共识(2024年版)

中国医师协会微无创医学专业委员会 · 2024-03-02